Ładuje się......
Intravesical Bacillus Calmette‐Guérin with interferon‐alpha versus intravesical Bacillus Calmette‐Guérin for treating non‐muscle‐invasive bladder cancer
BACKGROUND: Despite local therapies, commonly transurethral resection (TUR) followed by adjuvant treatments, non‐muscle‐invasive bladder cancer (NMIBC) has a high rate of recurrence and progression. Intravesical Bacillus Calmette‐Guérin (BCG) has been shown to reduce recurrence and progression in pe...
Zapisane w:
| Wydane w: | Cochrane Database Syst Rev |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley & Sons, Ltd
2017
|
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464648/ https://ncbi.nlm.nih.gov/pubmed/28268259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012112.pub2 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|